Investigation into the genetics of fetal congenital lymphatic anomalies
© 2023 The Authors. Prenatal Diagnosis published by John Wiley & Sons Ltd..
OBJECTIVE: Congenital lymphatic anomalies (LAs) arise due to defects in lymphatic development and often present in utero as pleural effusion, chylothorax, nuchal and soft tissue edema, ascites, or hydrops. Many LAs are caused by single nucleotide variants, which are not detected on routine prenatal testing.
METHODS: Demographic data were compared between two subcohorts, those with clinically significant fetal edema (CSFE) and isolated fetal edema. A targeted variant analysis of LA genes was performed using American College of Medical Genetics criteria on whole exome sequencing (WES) data generated for 71 fetal edema cases who remained undiagnosed after standard workup.
RESULTS: CSFE cases had poor outcomes, including preterm delivery, demise, and maternal preeclampsia. Pathogenic and likely pathogenic variants were identified in 7% (5/71) of cases, including variants in RASopathy genes, RASA1, SOS1, PTPN11, and a novel PIEZO1 variant. Variants of uncertain significance (VOUS) were identified in 45% (32/71) of cases. In CSFEs, VOUS were found in CELSR1, EPHB4, TIE1, PIEZO1, ITGA9, RASopathy genes, SOS1, SOS2, and RAF1.
CONCLUSIONS: WES identified pathogenic and likely pathogenic variants and VOUS in LA genes in 51% of fetal edema cases, supporting WES and expanded hydrops panels in cases of idiopathic fetal hydrops and fluid collections.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Prenatal diagnosis - 43(2023), 6 vom: 01. Juni, Seite 703-716 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rogerson, Daniella [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Ion Channels |
|---|
| Anmerkungen: |
Date Completed 12.06.2023 Date Revised 17.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/pd.6345 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM354642812 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM354642812 | ||
| 003 | DE-627 | ||
| 005 | 20231226062646.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/pd.6345 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1182.xml |
| 035 | |a (DE-627)NLM354642812 | ||
| 035 | |a (NLM)36959127 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rogerson, Daniella |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Investigation into the genetics of fetal congenital lymphatic anomalies |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.06.2023 | ||
| 500 | |a Date Revised 17.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 The Authors. Prenatal Diagnosis published by John Wiley & Sons Ltd. | ||
| 520 | |a OBJECTIVE: Congenital lymphatic anomalies (LAs) arise due to defects in lymphatic development and often present in utero as pleural effusion, chylothorax, nuchal and soft tissue edema, ascites, or hydrops. Many LAs are caused by single nucleotide variants, which are not detected on routine prenatal testing | ||
| 520 | |a METHODS: Demographic data were compared between two subcohorts, those with clinically significant fetal edema (CSFE) and isolated fetal edema. A targeted variant analysis of LA genes was performed using American College of Medical Genetics criteria on whole exome sequencing (WES) data generated for 71 fetal edema cases who remained undiagnosed after standard workup | ||
| 520 | |a RESULTS: CSFE cases had poor outcomes, including preterm delivery, demise, and maternal preeclampsia. Pathogenic and likely pathogenic variants were identified in 7% (5/71) of cases, including variants in RASopathy genes, RASA1, SOS1, PTPN11, and a novel PIEZO1 variant. Variants of uncertain significance (VOUS) were identified in 45% (32/71) of cases. In CSFEs, VOUS were found in CELSR1, EPHB4, TIE1, PIEZO1, ITGA9, RASopathy genes, SOS1, SOS2, and RAF1 | ||
| 520 | |a CONCLUSIONS: WES identified pathogenic and likely pathogenic variants and VOUS in LA genes in 51% of fetal edema cases, supporting WES and expanded hydrops panels in cases of idiopathic fetal hydrops and fluid collections | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a PIEZO1 protein, human |2 NLM | |
| 650 | 7 | |a Ion Channels |2 NLM | |
| 650 | 7 | |a RASA1 protein, human |2 NLM | |
| 650 | 7 | |a p120 GTPase Activating Protein |2 NLM | |
| 700 | 1 | |a Alkelai, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Giordano, Jessica |e verfasserin |4 aut | |
| 700 | 1 | |a Pantrangi, Madhulatha |e verfasserin |4 aut | |
| 700 | 1 | |a Hsiao, Meng-Chang |e verfasserin |4 aut | |
| 700 | 1 | |a Nhan-Chang, Chia-Ling |e verfasserin |4 aut | |
| 700 | 1 | |a Motelow, Joshua E |e verfasserin |4 aut | |
| 700 | 1 | |a Aggarwal, Vimla |e verfasserin |4 aut | |
| 700 | 1 | |a Goldstein, David |e verfasserin |4 aut | |
| 700 | 1 | |a Wapner, Ron |e verfasserin |4 aut | |
| 700 | 1 | |a Shawber, Carrie J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Prenatal diagnosis |d 1980 |g 43(2023), 6 vom: 01. Juni, Seite 703-716 |w (DE-627)NLM012597317 |x 1097-0223 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2023 |g number:6 |g day:01 |g month:06 |g pages:703-716 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/pd.6345 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2023 |e 6 |b 01 |c 06 |h 703-716 | ||